Login to Your Account



Pharma: Other News To Note


Monday, October 28, 2013

• H. Lundbeck A/S, of Valby, Denmark, said the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion and recommended marketing authorization for Brintellix (vortioxetine) to treat adults with major depressive episodes, or depression.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription